210 related articles for article (PubMed ID: 19133893)
1. New onsets of substance use disorders in borderline personality disorder over 7 years of follow-ups: findings from the Collaborative Longitudinal Personality Disorders Study.
Walter M; Gunderson JG; Zanarini MC; Sanislow CA; Grilo CM; McGlashan TH; Morey LC; Yen S; Stout RL; Skodol AE
Addiction; 2009 Jan; 104(1):97-103. PubMed ID: 19133893
[TBL] [Abstract][Full Text] [Related]
2. The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study.
Zanarini MC; Frankenburg FR; Weingeroff JL; Reich DB; Fitzmaurice GM; Weiss RD
Addiction; 2011 Feb; 106(2):342-8. PubMed ID: 21083831
[TBL] [Abstract][Full Text] [Related]
3. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study.
Gunderson JG; Stout RL; McGlashan TH; Shea MT; Morey LC; Grilo CM; Zanarini MC; Yen S; Markowitz JC; Sanislow C; Ansell E; Pinto A; Skodol AE
Arch Gen Psychiatry; 2011 Aug; 68(8):827-37. PubMed ID: 21464343
[TBL] [Abstract][Full Text] [Related]
4. Association of Borderline Personality Disorder Criteria With Suicide Attempts: Findings From the Collaborative Longitudinal Study of Personality Disorders Over 10 Years of Follow-up.
Yen S; Peters JR; Nishar S; Grilo CM; Sanislow CA; Shea MT; Zanarini MC; McGlashan TH; Morey LC; Skodol AE
JAMA Psychiatry; 2021 Feb; 78(2):187-194. PubMed ID: 33206138
[TBL] [Abstract][Full Text] [Related]
5. New episodes and new onsets of major depression in borderline and other personality disorders.
Gunderson JG; Stout RL; Sanislow CA; Shea MT; McGlashan TH; Zanarini MC; Daversa MT; Grilo CM; Yen S; Skodol AE
J Affect Disord; 2008 Nov; 111(1):40-5. PubMed ID: 18358539
[TBL] [Abstract][Full Text] [Related]
6. Does comorbid substance use disorder exacerbate borderline personality features? A comparison of borderline personality disorder individuals with vs. without current substance dependence.
Lee HJ; Bagge CL; Schumacher JA; Coffey SF
Personal Disord; 2010 Oct; 1(4):239-49. PubMed ID: 21116439
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study.
Wapp M; van de Glind G; van Emmerik-van Oortmerssen K; Dom G; Verspreet S; Carpentier PJ; Ramos-Quiroga JA; Skutle A; Bu ET; Franck J; Konstenius M; Kaye S; Demetrovics Z; Barta C; Fatséas M; Auriacombe M; Johnson B; Faraone SV; Levin FR; Allsop S; Carruthers S; Schoevers RA; Koeter MW; van den Brink W; Moggi F;
Eur Addict Res; 2015; 21(4):188-94. PubMed ID: 25832736
[TBL] [Abstract][Full Text] [Related]
8. Re-examining borderline personality disorder and substance use disorder: The role of emotion dysregulation.
Snow MB; Balling C; Zimmerman M
Ann Clin Psychiatry; 2020 Aug; 32(3):170-175. PubMed ID: 32343289
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.
van Emmerik-van Oortmerssen K; van de Glind G; Koeter MW; Allsop S; Auriacombe M; Barta C; Bu ET; Burren Y; Carpentier PJ; Carruthers S; Casas M; Demetrovics Z; Dom G; Faraone SV; Fatseas M; Franck J; Johnson B; Kapitány-Fövény M; Kaye S; Konstenius M; Levin FR; Moggi F; Møller M; Ramos-Quiroga JA; Schillinger A; Skutle A; Verspreet S; ; van den Brink W; Schoevers RA
Addiction; 2014 Feb; 109(2):262-72. PubMed ID: 24118292
[TBL] [Abstract][Full Text] [Related]
10. Impulsive clinical profile of Borderline Personality Disorder with comorbid Substance Use Disorder.
Calvo N; Valero S; Ferrer M; Barral C; Casas M
Actas Esp Psiquiatr; 2016 Jul; 44(4):145-52. PubMed ID: 27388106
[TBL] [Abstract][Full Text] [Related]
11. The two-faceted nature of impulsivity in patients with borderline personality disorder and substance use disorder.
Maraz A; Andó B; Rigó P; Harmatta J; Takách G; Zalka Z; Boncz I; Lackó Z; Urbán R; van den Brink W; Demetrovics Z
Drug Alcohol Depend; 2016 Jun; 163():48-54. PubMed ID: 27107850
[TBL] [Abstract][Full Text] [Related]
12. Symptoms of anxiety, depression, and borderline personality in alcohol use disorder with and without comorbid substance use disorder.
Howe LK; Fisher LR; Atkinson EA; Finn PR
Alcohol; 2021 Feb; 90():19-25. PubMed ID: 33232791
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
[TBL] [Abstract][Full Text] [Related]
14. Predictors of 2-year outcome for patients with borderline personality disorder.
Gunderson JG; Daversa MT; Grilo CM; McGlashan TH; Zanarini MC; Shea MT; Skodol AE; Yen S; Sanislow CA; Bender DS; Dyck IR; Morey LC; Stout RL
Am J Psychiatry; 2006 May; 163(5):822-6. PubMed ID: 16648322
[TBL] [Abstract][Full Text] [Related]
15. Residential eating disorder outcomes associated with screening positive for substance use disorder and borderline personality disorder.
Weigel TJ; Wang SB; Thomas JJ; Eddy KT; Pierce C; Zanarini MC; Fitzmaurice G; Busch A
Int J Eat Disord; 2019 Mar; 52(3):309-313. PubMed ID: 30746736
[TBL] [Abstract][Full Text] [Related]
16. Prospective follow-up study of borderline personality disorder: prognosis, prediction of outcome, and Axis II comorbidity.
Links PS; Heslegrave R; van Reekum R
Can J Psychiatry; 1998 Apr; 43(3):265-70. PubMed ID: 9561315
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing bipolar II depression from major depressive disorder with comorbid borderline personality disorder: demographic, clinical, and family history differences.
Zimmerman M; Martinez JH; Morgan TA; Young D; Chelminski I; Dalrymple K
J Clin Psychiatry; 2013 Sep; 74(9):880-6. PubMed ID: 24107761
[TBL] [Abstract][Full Text] [Related]
18. Substance abuse patterns and their association with psychopathology and type of hostility in male patients with borderline and antisocial personality disorder.
Hatzitaskos P; Soldatos CR; Kokkevi A; Stefanis CN
Compr Psychiatry; 1999; 40(4):278-82. PubMed ID: 10428187
[TBL] [Abstract][Full Text] [Related]
19. Axis II comorbidity of borderline personality disorder: description of 6-year course and prediction to time-to-remission.
Zanarini MC; Frankenburg FR; Vujanovic AA; Hennen J; Reich DB; Silk KR
Acta Psychiatr Scand; 2004 Dec; 110(6):416-20. PubMed ID: 15521825
[TBL] [Abstract][Full Text] [Related]
20. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology.
Zanarini MC; Vujanovic AA; Parachini EA; Boulanger JL; Frankenburg FR; Hennen J
J Pers Disord; 2003 Jun; 17(3):233-42. PubMed ID: 12839102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
